PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
Retroperitoneal lymphadenectomy, often referred to as RPLND, is a specialized surgical procedure performed to remove lymph nodes located at the back of the abdominal cavity—the retroperitoneum. These lymph nodes play a central role in how certain cancers, especially testicular cancer, spread. Because of that, RPLND is both a diagnostic and therapeutic tool that can significantly influence long-term outcomes.
This procedure is typically performed by experienced surgical oncologists and requires a deep understanding of abdominal anatomy, cancer pathways, and nerve-sparing techniques. For many patients, RPLND offers a chance for cure without the need for additional treatments.
RPLND involves removing lymph nodes situated near major blood vessels such as the aorta and inferior vena cava. These nodes are a common route of metastasis for germ cell tumors, particularly non-seminomatous testicular cancer.
The surgery can be performed through a traditional open approach or, in selected cases, through minimally invasive or robotic-assisted techniques.
RPLND is performed for several clinical indications:
RPLND is most commonly used in patients with:
Non-seminomatous germ cell tumors
Residual masses after chemotherapy
Early-stage cancers where surgery may prevent overtreatment
The procedure can accurately determine whether cancer has spread beyond the testicle, which helps guide further management.
Even when imaging suggests a stable mass, RPLND helps confirm whether it contains:
Active cancer cells
Scar tissue
Teratoma, which does not respond to chemotherapy
This distinction is crucial, as teratoma must be surgically removed.
Though rare, RPLND may be used in:
Certain gynecologic cancers
Retroperitoneal tumors
Lymphatic diseases requiring targeted node removal
For many early-stage patients, RPLND alone may completely eliminate cancerous spread, avoiding the need for chemotherapy or radiation.
By analyzing removed lymph nodes, doctors can:
Determine if microscopic cancer remains
Tailor follow-up treatment plans
Avoid unnecessary therapies
RPLND significantly reduces the risk of relapse in appropriately selected patients.
Modern surgical methods aim to preserve:
Ejaculatory function
Fertility potential
Quality of life
This has improved sexual and reproductive outcomes for many patients.
Patients undergo:
CT or MRI imaging
Tumor marker review
Cardiovascular and anesthesia assessment
During the operation, the surgeon:
Carefully accesses the retroperitoneal space
Identifies and removes targeted lymph nodes
Uses nerve-sparing techniques whenever possible
The duration varies from 2 to 4 hours depending on technique and complexity.
Most patients experience:
A hospital stay of several days
Gradual return to normal activities over a few weeks
Regular follow-up to monitor tumor markers and healing
Like all major surgeries, RPLND carries potential risks, including:
Temporary digestive upset
Lymphatic leakage
Infection or bleeding
Ejaculatory dysfunction (significantly reduced with nerve-sparing techniques)
However, with an experienced team, complications are minimized and outcomes are generally excellent.
Despite advances in chemotherapy and targeted therapies, RPLND still holds a vital place in cancer management. It offers clarity, precision, and in many cases, a direct path to cure. For young patients especially—who make up the majority of testicular cancer cases—understanding all treatment options is essential for making empowered decisions.
WhatsApp us